Dynamic transitions of mature osteoblasts between active and quiescent states are essential for bone homeostasis and present a promising target for osteoanabolic therapy.However,these transitions remain poorly underst...Dynamic transitions of mature osteoblasts between active and quiescent states are essential for bone homeostasis and present a promising target for osteoanabolic therapy.However,these transitions remain poorly understood due to cellular heterogeneity and limited spatial context.Here,we employed spatially resolved osteoblast-traced transcriptomics,integrating an osteoblast-specific lineage tracing study and spatially resolved laser-activated cell sorting(SLACS),to profile osteoblast states on quiescent bone surfaces.This approach identified transforming growth factor-beta(TGF-β)signaling as a regulator of osteoblast activation.We further validated this role using single-cell RNA sequencing,in vitro functional assays,and in vivo.In a hindlimb unloading mouse model,dual inhibition of TGF-βand sclerostin enhanced bone mass and mitigated bone loss more effectively than sclerostin inhibition alone.These findings reveal a mechanistic role for TGF-βin regulating osteoblast dynamics and propose a dual-target therapeutic strategy that enhances the efficacy of anti-sclerostin treatment in osteoporosis.展开更多
基金supported by grants from the National Research Foundation of Korea(2023R1A2C2003958 to S.W.K.)Boramae Medical Center(02-2020-9 to S.W.K and S.K)+2 种基金the Korea-US Collaborative Research Fund(KUCRF),funded by the Ministry of Science and ICT and Ministry of Health&Welfare,Republic of Korea(RS2024-00508416)the Industrial Strategic Technology Development Program funded by the Ministry of Trade Industry&Energy(MOTIE)of Republic of Korea(RS-2024-00508416 to S.K.)the BK21 FOUR program of the Education and Research Program for Future ICT Pioneers(Seoul National University in 2025)。
摘要Dynamic transitions of mature osteoblasts between active and quiescent states are essential for bone homeostasis and present a promising target for osteoanabolic therapy.However,these transitions remain poorly understood due to cellular heterogeneity and limited spatial context.Here,we employed spatially resolved osteoblast-traced transcriptomics,integrating an osteoblast-specific lineage tracing study and spatially resolved laser-activated cell sorting(SLACS),to profile osteoblast states on quiescent bone surfaces.This approach identified transforming growth factor-beta(TGF-β)signaling as a regulator of osteoblast activation.We further validated this role using single-cell RNA sequencing,in vitro functional assays,and in vivo.In a hindlimb unloading mouse model,dual inhibition of TGF-βand sclerostin enhanced bone mass and mitigated bone loss more effectively than sclerostin inhibition alone.These findings reveal a mechanistic role for TGF-βin regulating osteoblast dynamics and propose a dual-target therapeutic strategy that enhances the efficacy of anti-sclerostin treatment in osteoporosis.